Clinical Trial

Effect of Amnio-Maxx on the Healing Rate of Chronic Diabetic Foot Ulcers.

Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated October 7, 2025 (before its estimated August 14, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study will evaluate a cellular, acellular, matrix-like product (CAMP) and Standard of Care (SOC) versus SOC alone in the closure of nonhealing diabetic foot ulcers (DFUs). The study will evaluate Amnio-Maxx® Dual Layer Amnion Patch.
Trial Details
NCT Number NCT07209475
Lead Sponsor Royal Biologics
Conditions Diabetic Foot Ulcer (DFU), Amnio-Maxx
Enrollment 248 participants
Start Date 2025-08-14
Primary Completion 2026-08-14 (estimated)
Study Completion 2026-08-14 (estimated)
Updated on ClinicalTrials.gov 2025-10-07